ArticleJournal of thoracic disease2016

A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer.

Jae Kil Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.